pathology review service

A typical pathologist review begins with sample receipt and documentation, where we verify your slides or tissue blocks and catalog them with complete tracking. Next, we assign a board-certified pathologist with expertise relevant to your study species, organ system, and therapeutic area. The pathologist performs detailed microscopic evaluation of stained slides, examining tissue architecture, cellular morphology, and pathological changes. Findings are documented with digital images and scored against your study endpoints using standardized or custom scales. Finally, we generate a comprehensive report with interpretations, scoring data, and high-resolution images formatted to meet publication or regulatory submission requirements. Throughout the process, you can consult directly with the reviewing pathologist.

Digital pathology significantly improves review accuracy through high-resolution scanning that captures complete slide detail at multiple magnifications, enabling detailed examination that can support detailed review with consistent viewing, annotation, and quantification tools. Quantitative image analysis tools provide objective, reproducible measurements of tissue features like cell counts, staining intensity, and tissue area, reducing inter-observer variability by using standardized scoring and quantitative measures where appropriate. Side-by-side digital comparison allows consistent evaluation across multiple samples and time points. For efficiency, digital pathology enables remote access to slides without shipping delays, multi-user collaborative viewing for real-time consultation, integrated annotation and reporting tools that streamline documentation, and long-term digital archiving for easy retrieval and quality control. The combination of these features often improves collaboration and can shorten cycle time by enabling remote review.

We support most common sample types (FFPE, frozen sections, IHC/ISH, special stains) and multiple species (rodent, canine, primate, human). Tell us your model and tissues—coverage depends on scope and staining quality. Our pathologists handle samples from safety toxicology studies, efficacy studies, mechanism of action investigations, biomarker validation, and IND-enabling studies.

Absolutely. We encourage direct consultation between researchers and our pathologists. You can schedule consultations before the review begins to discuss study objectives and scoring criteria, during the review to address preliminary findings or questions, and after report delivery to interpret complex results or discuss implications for study design. We view ourselves as partners in your therapeutic development process, not just a service provider. This consultative approach ensures our pathology reviews deliver maximum value for your decision-making.

Our reviews can support regulatory packages by providing board-certified interpretation, standardized terminology, and clear documentation. We are not a clinical diagnostic lab, and final submission suitability depends on your study context (e.g., GLP/non-GLP), sponsor requirements, and your QA program.

Yes, we understand that timelines can be critical in therapeutic development. While our standard turnaround is 1-2 weeks (already faster than most pathology services), we offer expedited review options for urgent projects. Contact us to discuss your timeline requirements, and we'll work to accommodate your needs while maintaining our quality standards. Rush fees may apply depending on the scope and urgency.